Intelligence · Patents
Patents expiring in 2028
Annual patent cliff calendar for 2028 — US pharmaceutical patents by expiration date.
- Patents
- 624
Quick answer
624 indexed pharmaceutical patents have expiration dates in 2028. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7396860
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
granted -
US 7396918
IGF-I fusion polypeptides and therapeutic uses thereof
granted -
US 7396682
Method for cell adhesion and wound healing
granted -
US 7396542
Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
granted -
US 7396664
VEGF-binding fusion proteins and nucleic acids encoding the same
granted -
US 7399485
Rapidly Disintegrable solid preparation
granted -
US 7399606
Methods for identifying IκB Kinase (IKK) inhibitors
granted -
US 7399827
Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
granted -
US 7399823
Antimicrobial theta defensins and methods of using same
granted -
US 7399863
Amino-substituted ethylamino β2 adrenergic receptor agonists
granted -
US 7399862
5-HT4 receptor agonist compounds
granted -
US 7399465
Pharmaceutical compositions for treating arthritis and inflammatory disease
granted -
US 7399488
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
granted -
US 7399612
VEGF-binding fusion proteins and nucleic acids encoding the same
granted -
US 7399759
1, 3-benzothiazinone derivatives and use thereof
granted -
US 7399750
Methods for cardiac gene transfer
granted -
US 7402299
Intracorporeal medicaments for photodynamic treatment of disease
granted -
US 7402673
Diamine β2 adrenergic receptor agonists
granted -
US 7402567
Treatment of disease by inducing cell apoptosis
granted -
US 7402659
Thymic stromal lymphopoietin receptor molecules and uses thereof
granted -
US 7402595
JNK inhibitor
granted -
US 7402590
Spiroazacyclic compounds as monoamine receptor modulators
granted -
US 7402578
Methods for inhibiting cognitive deterioration in adults with down's syndrome
granted -
US 7405286
Stars—A muscle-specific actin-binding protein
granted -
US 7405302
5-lipoxygenase-activating protein (FLAP) inhibitors
granted -
US 7405266
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7405233
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
granted -
US 7405202
CRISP polypeptides as contraceptives and inhibitors of sperm capacitation
granted -
US 7405199
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7404961
Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
granted -
US 7404954
Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor
granted -
US 7405041
Methods for regulating transcription by targeting quadruplex DNA
granted -
US 7404956
Immunoglobulin chimeric monomer-dimer hybrids
granted -
US 7405314
Compounds and methods for the treatment of cancer
granted -
US 7405287
Method of treating a cancer
granted -
US 7408075
Synthesis of phosphocholine ester derivatives and conjugates thereof
granted -
US 7407964
Caspase inhibitors and uses thereof
granted -
US 7407939
Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics
granted -
US 7407935
Ricin toxin A-chain fragment for use as a vaccine
granted -
US 7407976
Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
granted -
US 7407656
PSCA: prostate stem cell antigen and uses thereof
granted -
US 7407962
Heteroaryl compounds useful as inhibitors or protein kinases
granted -
US 7407664
Peptide vaccines against group A streptococci
granted -
US 7407658
Vaccines for blocking transmission of plasmodium vivax
granted -
US 7410665
Coated implantable medical device
granted -
US 7410644
Recombinant pox virus for immunization against tumor-associated antigens
granted -
US 7411076
Coumarin derivative
granted -
US 7410758
Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
granted
Frequently asked questions
How many pharma patents expire in 2028?
624 published patents in our USPTO index have expiration dates falling in calendar year 2028.